These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Search MEDLINE/PubMed


  • Title: [Congenital percutaneous aortic valvuloplasty in 70 subjects with congenital aortic stenosis, mid-term results].
    Author: Alva C, Sánchez A, Jiménez S, David F, Ortegón J, Hernández M, Ledesma M.
    Journal: Gac Med Mex; 2004; 140(3):269-72. PubMed ID: 15259337.
    Abstract:
    OBJECTIVE: To evaluate mid-term results with Percutaneous aortic valvuloplasty (PAV). MATERIAL AND METHODS: Records of 70 patients treated with percutaneous aortic valvuloplasty with at least 6 months follow-up were reviewed. RESULTS: The 70 patients with PAV aged 3 months to 36 years, mean 10.5 +/- 10.6 years, 40) 63%) were male and 26 (37%) female. Initial systolic peak gradient decreased from 84 +/-20 to 31 +/- 16 mmHg (p < 0.05), while the reduction percentage ranged from 25 to 100%, mean 60 +/- 22. Balloon/aortic annulus index was 0.9 +/- 0.17. Ten (14.1 %) patients developed aortic insufficiency after PAV. Follow-up ranged from 6 to 168 months, mean +/- 48 months. At end of follow-up, 21 patients (30%) were considered failed cases and 49 (70%) patients had a successful outcome. CONCLUSIONS: This study showed a series with the longest follow-up in Latin America with PAV. New prospective and multicentric studies are needed in this region.
    [Abstract] [Full Text] [Related] [New Search]